A facile route for the synthesis 1,4-disubstituted tetrazolone derivatives and evaluation of their antimicrobial activity

Medicinal Chemistry Research

Volumn 22, Issue 7, 2013, Pages 3329-3340

  Santhoshi, Amlipur ^a   Sadhu, Partha Sarathi ^a   Sriram, Rekulapally ^b   Sai Pavan Kumar, Chebolu Naga Sesha ^a   Mahendar, Budde ^a   Sarangapani, Manda ^b   Rao, Vaidya Jayathirtha ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b KAKATIYA UNIVERSITY   (India)

Author keywords

Antimicrobial evaluation; Baylis Hillman bromides; Drug resistant; Gram negative bacteria; Gram positive bacteria; Tetrazolones

Indexed keywords

(E) ETHYL3 (4 CHLOROPHENYL) 2 [(5 OXO 4 PHENYL 4,5 DIHYDRO 1H TETRAZOL 1 YL)METHYL]ACRYLATE; (E) ETHYL3 (4 CHLOROPHENYL) 2 [[4 (4 METHOXYPHENYL) 5 OXO 4,5 DIHYDRO 1H TETRAZOL 1 YL]METHYL]ACRYLATE; (E) METHYL3 (4 FLUOROPHENYL) 2 [[4 (4 METHOXYPHENYL) 5 OXO 4,5 DIHYDRO 1H TETRAZOL 1 YL]METHYL]ACRYLATE; (E) METHYL3 (4 METHOXYPHENYL) 2 [[4 (4 METHOXYPHENYL) 5 OXO 4,5 DIHYDRO 1H TETRAZOL 1 YL]METHYL]ACRYLATE; (Z) 2 [[4 (4 METHOXYPHENYL) 5 OXO 4,5 DIHYDRO 1H TETRAZOL 1YL]METHYL] 3 P TOLYLACRYLONITRILE; (Z) 2 [[5 OXO 4 [4 (TRIFLUOROMETHYL)PHENYL] 4,5 DIHYDRO 1H TETRAZOL 1 YL]METHYL] 3 PHENYLACRYLONITRILE; (Z) 3 (4 METHOXYPHENYL) 2 [[4 (4 METHOXYPHENYL)] 5 OXO 4,5 DIHYDRO 1H TETRAZOL 1YL]METHYL]ACRYLONITRILE; (Z) 3 (4 METHOXYPHENYL) 2 [[5 OXO 4 [4 (TRIFLUOROMETHYL)PHENYL] 4,5 DIHYDRO 1H TETRAZOL 1 YL]METHYL]ACRYLONITRILE; ANTIFUNGAL AGENT; CIPROFLOXACIN; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS SUBTILIS; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; DRUG SYNTHESIS; NONHUMAN; STAPHYLOCOCCUS AUREUS; STEREOCHEMISTRY;

EID: 84878865430     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0331-4     Document Type: Article

References (39)

1. Abbott FS, Acheampong AA (1988) Quantitative structure-anticonvulsant activity relationships of valproic acid, related carboxylic acids and tetrazoles. Neuropharmacology 27:287-294
2. Adamec J, Waisser K, Kunes J, Kaustova J (2005) A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles. Arch Pharm 338:385-389
3. Andriole VT, Bodey GP (1994) Pocket guide to systemic antifungal therapy. Scientific Therapeutics, Springfield
4. Arias CA, Murray BE (2009) Antibiotic-resistant bugs in the 21st century - a clinical super-challenge. N Engl J Med 360:439-443
5. Basavaiah D, Sarma PKS, Bhavani AKD (1994) Applications of the Baylis-Hillman reaction 2: a simple stereoselective synthesis of (E)- and (Z)-trisubstituted alkenes. J Chem Soc Chem Commun 9:1091-1092
6. Basavaiah D, Reddy BS, Badsara SS (2010) Recent contributions from the Baylis-Hillman reaction to organic chemistry. Chem Rev 110:5447-5674
7. Bodey GP (1993) Candidosis: pathogenesis, diagnosis and treatment. Raven, New York, pp 371-406
8. 3 adrenergic receptor agonist. Tetrahedron Lett 40:6739-6743
9. Current WL, Tang J, Boylan C, Watson P, Zechkner D, Turner W, Rodriguez M, Dixon C, Ma D, Radding JA (1995) Glucan biosynthesis as a target for antifungals: the echinocandin class of antifungal agents. In: Dixon GK, Copping LG, Hollomon DW (eds) Antifungal agents: discovery and mode. BIOS, Oxford, pp 143-160
10. De Souza AO, Pedrosa MT, Alderete JB, Cruz AF, Prado MA, Alves RB, Silva CL (2005) Cytotoxicity, antitumoral and antimycobacterial activity of tetrazole and oxadiazole derivatives. Pharmazie 60:396-397
11. De Souza ROMA, LP Pereira V, Muzitano MF, Falcao CAB, Rossi-Bergmann B, Filho EBA, Vasconcellos MLAA (2007) High selective leishmanicidal activity of 3-hydroxy-2-methylene-3-(4-bromophenyl)propanenitrile and analogous compounds. Eur J Med Chem 42:99-102
12. Dessen A, Di Guilmi AM, Vernet T, Dideberg O (2001) Molecular mechanisms of antibiotic resistance in Gram-positive pathogens. Curr Drug Targets Infect Disord 1:63-77
13. ECDC (2010) Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net); European centre for disease prevention and control: Stockholm
14. Hashimoto Y, Ohashi R, Kurosawa Y, Minami K, Kaji H, Hayashida K, Narita H, Murata S (1998) Pharmacologic profile of TA-606, a novel angiotensin II-receptor antagonist in the rat. J Cardiovasc Pharmacol 31:568-575
15. Klaubert HD, Sellstedt JH, Guinosso CJ, Bell SC, Capetola RJ (1981) 5-Tetrazolecarboxamides and their salts: new orally active antiallergy agents. J Med Chem 24:748-752
16. Kundu MK, Sundar N, Kumar SK, Bhat SV, Biswas S, Valecha N (1999) Antimalarial activity of 3-hydroxyalkyl-2-methylene-propionic acid derivatives. Bioorg Med Chem Lett 9:731-736
17. Leclercq R (2009) Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci. Clin Microbiol Infect 15:224-231
18. Lim SJ, Sunohara Y, Matsumoto H (2007) Action of fentrazamide on protein metabolism and cell division in plants. J Pest Sci 32:249-254
19. Lock RL, Harry EJ (2008) Cell-division inhibitors: new insights for future antibiotics. Nat Rev Drug Discov 7:324-338
20. Narender P, Srinivas U, Gangadasu B, Biswas S, Jayathirtha Rao V (2005) Anti-malarial activity of Baylis-Hillman adducts from substituted 2-chloronicotinaldehydes. Bioorg Med Chem Lett 15:5378-5381
21. Narender P, Srinivas U, Ravinder M, AnandRao B, Ramesh Ch, Harakishore K, Gangadasu B, Murthy USN, Jayathirtha Rao V (2006) Synthesis of multisubstituted quinolines from Baylis-Hillman adducts obtained from substituted 2-chloronicotinaldehydes and their antimicrobial activity. Bioorg Med Chem 14:4600-4609
22. O'Meara JA, Jakalian A, La Plante S, Bonneau PR, Coulombe R, Faucher AM, Guse I, Landry S, Racine J, Simoneau B, Thavonekham B, Yoakim C (2007) Scaffold hopping in the rational design of novel HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg Med Chem Lett 17:3362-3366
23. Pavan Kumar CNSS, Parida DK, Santhoshi A, Kota AK, Sridhar B, Jayathirtha Rao V (2011) Synthesis and biological evaluation of tetrazole containing compounds as possible anticancer agents. Med Chem Commun 2:486-492
24. Pfeltz RF, Wilkinson BJ (2004) The escalating challenge of vancomycin resistance in Staphylococcus aureus. Curr Drug Targets Infect Disord 4:273-294
25. Rao SN, Ravisankar T, Latha J, Babu KS (2012) Synthesis, characterization and antimicrobial activity of novel biphenyl tetrazoles. Der Pharma Chemica 4:1093-1103
26. Ravinder M, Sadhu PS, Jayathirtha Rao V (2009) Simple, facile and one-pot conversion of the Baylis-Hillman acetates into 3, 5, 6-trisubstituted-2- pyridones. Tetrahedron Lett 50:4229-4232
27. Ravinder M, Sadhu PS, Santhoshi A, Narender P, Gundimella YSKS, Ravikumar K and Jayathirtha Rao V (2010) Synthesis of new amino nicotinate derivatives from acetylated Baylis-Hillman adducts and enamino esters via a consecutive [3 + 3] annulation protocol. Synthesis 573-578
28. Sandmann GI, Schneider C, Boger PZ (1991) A new non-radioactive assay of phytoene desaturase to evaluate bleaching herbicides. Z Naturforsch C 51:534-538
29. Schocken MJ, Creekmore RW, Theodoridis G, Nystrom GJ, Robinson RA (1989) Microbial transformation of the tetrazolinone herbicide f5231. Appl Environ Microbiol 55:1220-1222
30. Shigetomi K, Kishimoto T, Shoji K, Ubukata M (2008) First total synthesis of 6-tuliposide B. Tetrahedron Asymmetry 19:1444-1449
31. 3 adrenergic receptor agonist with improved oral bioavailability. Bioorg Med Chem Lett 9:1251-1254
32. Silva FPL, de Assis PAC, Junior CGL, de Andrade NG, da Cunha SMD, Oliveira MR, Mário LAA, Vasconcellos MLAA (2011) Synthesis, evaluation against Leishmania amazonesis and cytotoxicity assays in macrophages of sixteen new congeners Morita-Baylis-Hillman adducts. Eur J Med Chem 46:4295-4301
33. Singh V, Batra S (2008) Advances in the Baylis-Hillman reaction-assisted synthesis of cyclic frameworks. Tetrahedron 64:4511-4574
34. Singh H, Chawla AS, Kapoor VK, Paul D, Malhotra RK (1980) Medicinal chemistry of tetrazoles. Prog Med Chem 17:151-183
35. Su XY, Wei CX, Deng XQ, Sum ZG, Quan ZS (2010) Evaluation of the anticonvulsant activity of 6-(4-chlorophenyoxy)-tetrazolo[5, 1-a]phthalazine in various experimental seizure models in mice. Pharmacol Rep 62:273-277
36. Tenovera FC (2001) Development and spread of bacterial resistance to antimicrobial agents: an overview. Clin Infect Dis 33:S108-S115
37. Tsuge O, Urano S, Oe K (1980) Reactions of trimethylsilyl azide with heterocumulenes. J Org Chem 45:5130-5136
38. Wexler RR, Greenlee WJ, Irvin JD, Goldberg MR, Prendergast K, Smith RD, Timmermans PBMWM (1996) Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. J Med Chem 39:625-655
39. Zhan P, Li Z, Liu X, De Clercq E (2009) Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs. Mini Rev Med Chem 9:1014-1023